Steven K Galson - Net Worth and Insider Trading
Steven K Galson Net Worth
The estimated net worth of Steven K Galson is at least $417,821 dollars as of 2024-09-20. Steven K Galson is the Director of BioCryst Pharmaceuticals Inc and owns about 51,551 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $417,821. Details can be seen in Steven K Galson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven K Galson has not made any transactions after 2024-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven K Galson
Steven K Galson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven K Galson owns 2 companies in total, including Vanda Pharmaceuticals Inc (VNDA) , and BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Steven K Galson’s form 4 insider trades.
Insider Ownership Summary of Steven K Galson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc | 2010-07-01 | director |
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | director |
Steven K Galson Latest Holdings Summary
Steven K Galson currently owns a total of 1 stock. Steven K Galson owns 51,551 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 13, 2024, with a value of $417,821.
Latest Holdings of Steven K Galson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | 51,551 | 8.11 | 417,821 |
Holding Weightings of Steven K Galson
Steven K Galson Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven K Galson has made a total of 1 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 21,940 shares on May 13, 2024, which cost Steven K Galson around $120,451.
Insider Trading History of Steven K Galson
- 1
Steven K Galson Trading Performance
GuruFocus tracks the stock performance after each of Steven K Galson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven K Galson is 40.14%. GuruFocus also compares Steven K Galson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven K Galson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven K Galson's insider trading performs compared to the benchmark.
Performance of Steven K Galson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.66 |  | | | | |
| Relative Return to S&P 500(%) | 6.59 | | | | | |
Steven K Galson Ownership Network
Steven K Galson Owned Company Details
What does Vanda Pharmaceuticals Inc do?
Who are the key executives at Vanda Pharmaceuticals Inc?
Steven K Galson is the director of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include VP & Acting CFO & Treasurer Kevin Patrick Moran , director & Chief Executive Officer Mihael Hristos Polymeropoulos , and SVP & General Counsel Timothy Williams .
Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary
Over the past 18 months, Steven K Galson made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 35,163 shares made by Kevin Patrick Moran , a net sale of 31,688 shares made by Timothy Williams , and a net sale of 20,451 shares made by Joakim Wijkstrom .
In summary, during the past 3 months, insiders sold 2,251 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 2,251 shares. During the past 18 months, 166,385 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 166,385 shares.
Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vanda Pharmaceuticals Inc Insider Transactions
Steven K Galson Mailing Address
Above is the net worth, insider trading, and ownership report for Steven K Galson. You might contact Steven K Galson via mailing address: C/o Biocryst Pharmaceuticals, Inc., 4505 Emperor Blvd, Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
